The Cancer Research Concentration @ Leaders in Pharmaceutical Business Intelligence
Author: Aviva Lev-Ari, PhD, RN
This Report has the following Parts:
PART 1: Three SCENARIOS for Marketing the Cancer Research Concentration @ Leaders in Pharmaceutical Business Intelligence (LPBI)
PART 2: Cancer Content Indexing –
Scenario A – Articles on Cancer-Related Topic in http://pharmaceuticalintelligence.com – Open Access Online Scientific Journal
PART 3: Internet EXPOSURE: Global VIEWS of Articles on Cancer-Related Topic in http://pharmaceuticalintelligence.com – Articles viewed by e-Readers more than 500 times
PART 4: Content Curations in e-Publishing –
Scenario B – BioMed e-Series C: Cancer and Oncology
http://pharmaceuticalintelligence.com/biomed-e-books/series-c-e-books-on-cancer-oncology/
e-Books on Cancer, Volume One, Volume Two, Volume Three
- Volume One: Cancer Biology and Genomics for Disease Diagnosis
- Volume Two: Radiation Therapy and Immunotherapy in Oncology
- Volume Three: Nanotechnology in Drug Discovery and Drug Delivery
- Volume Four: Cancer Patients’ Resources on Therapies
PART 5: Publications on Cancer & Oncology by LPBI’s Cancer Research Team
Scenario C: Cancer Research Team @ Leaders in Pharmaceutical Business Intelligence (LPBI) –+10 MDs & PhDs, LPBI’s Expert, Authors, Writers
http://pharmaceuticalintelligence.com/contributors-biographies/
PART 6: Protected: Prospective Business Partners and Valuation of Scenarios A & B & C
PART 7: Cancer-related Pharma and Biotech Companies in Switzerland and in Germany
PART 1:Three SCENARIOS for Marketingthe Cancer Research Concentration@ Leaders in Pharmaceutical Business Intelligence(LPBI)
|
|||
SCENARIOS | A | B | C |
Prospect Business Partner See Legend for URLs and Scenarios’ Description |
PI 100 categories of Cancer-related Research + 600 articles | e-Books: Volume One and Volume Two | Cancer Team: 10 PhDs, EAWs |
Coriell Institute for Medical Research 403 Haddon Avenue | Camden, NJ 08103 Phone: 856-966-7377 |
yes | yes | yes |
Biobanks in Europe by Countryhttp://ftp.jrc.es/EURdoc/JRC57831.pdf | yes | yes | no |
SaaS:
|
yes | yes | no |
genome.gov | yes | yes | no |
LEK Consulting | yes | yes | yes |
knome.com | yes | yes | some |
Institute of Molecular Life Sciences, University of Zurich, Zurich | yes | yes | no |
Li Ka Shing Center for Genomic Engineering, UCB, UCSF | yes | yes | no |
Elsevier Pathway Studio | yes | yes | some |
Univ. of Michigan (U-M) & OncoFusion Therapeutics Inc. | yes | yes | no |
Thomson Reuters CorporationGenoSpace, Thomson Reuters:PathGroup Cancer Testing Service,Cortellis’ Data Integration and Analytics,Oncology Treatment Life Sciences Coalition | yes | yes | no |
SRI Int’l, Genomic Health w/Cleveland Clinic, Myriad Genetics w/UCSF, GenomeDx and BioTheranostics, | yes | yes | yes |
FOUNDATIONS | yes | yes | no |
LEGEND
1. Prospect Business Partner
1.1 Coriell Institute for Medical Research
403 Haddon Avenue | Camden, NJ 08103
Phone: 856-966-7377
1.2 Biobanks in Europe by Country,
http://ftp.jrc.es/EURdoc/JRC57831.pdf
1.3 International SaaS: SAS, SAP, Mathworks, Oracle
1.4 genome.gov
http://pharmaceuticalintelligence.com/2013/06/02/genomics-online-research-resources-genome-gov/
1.5 LEKConsulting
LEK Report:
1.6 knome.com
1.7 Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland – michael.baudis@imls.uzh.ch
1.8 Li Ka Shing Center for Genomic Engineering, UCB, UCSF
1.9 ELSEVIER – Elsevier Pathway Studio,
http://www.elsevier.com/online-tools/pathway-studio
1.10 Univ. of Michigan (U-M)
startup developing drugs to target gene fusions that drive many common cancers such as breast, colon, prostate and lung has signed a research and license agreement with a California biopharmaceutical company, OncoFusion Therapeutics Inc., Profs. Arul Chinnaiyan and Shaomeng Wang, http://www.rdmag.com/news/2014/04/u-m-startup-signs-license-agreement-drug-company
1.11 GenoSpace, Thomson Reuters: PathGroup Cancer Testing Service, Cortellis’ Data Integration and Analytics, Oncology Treatment Life Sciences Coalition (Thomson Reuters Corporation) GenoSpace, Thomson Reuters: PathGroup Cancer Testing Service, Cortellis’ Data Integration and Analytics, Oncology Treatment Life Sciences Coalition (Thomson Reuters Corporation), http://www.reuters.com/article/2014/03/11/tn-pathgroup-idUSnBw116205a+100+BSW20140311
1.12 Prostate Cancer Molecular Diagnostic Market – the Players are: SRI Int’l, Genomic Health w/Cleveland Clinic, Myriad Genetics w/UCSF, GenomeDx and BioTheranostics, http://pharmaceuticalintelligence.com/2013/05/21/prostate-cancer-molecular-diagnostic-market-the-players-are-sri-intl-genomic-health-wcleveland-clinic-myriad-genetics-wucsf-genomedx-and-biotheranostics/
1.13 FOUNDATIONS : List of Contacts
- Louis J. DeGennaro, Interim President and CEO, Chief Mission Ocer, The Leukemia and Lymphoma Society
- Darryl Mitteldorf, Executive Director, Global Prostate Cancer Alliance
- Kristina Khodova, Head of Oncology Projects, Biomed Cluster,Skolkovo Foundation
- Louise M. Perkins, Chief Science Ocer, Melanoma Research Alliance
- Peter L. Hoang, Managing Director, Oce of Innovations, Technology Based Ventures, The University of Texas MD Anderson Cancer Center
- Steven Young, President & COO, Addario Lung Cancer Medical Institute
- Walter M. Capone, President, Multiple Myeloma Research Foundation
- Ronald H. Goldfarb, PhD, President, Trudeau Institute, Saranac Lake, NY
PART 2:Cancer Content IndexingScenario AArticles on Cancer-Related Topic in http://pharmaceuticalintelligence.comOpen Access Online Scientific Journal
Curator: Stephen J Williams, PhD
5/5/2014 – OUT OF 1892 articles to date 746 involve the keyword CANCER
|
PART 3:
Internet EXPOSURE: Global VIEWS of Articles on
Cancer-Related Topic in
http://pharmaceuticalintelligence.com
Articles viewed by e-Readers more than 500 times
in bold more than 1,000
Semantic Classification of Articles’ Title Content: Stephen, J Williams, PhD
Is the Warburg Effect the Cause or the Effect of Cancer: A 21st Century View?
5,408
Contributors’ Biographies
2,555
Mesothelin: An early detection biomarker for cancer (By Jack Andraka)
2,541
About
1,912
BioMed e-Series
1,903
Problems of vegetarianism
1,872
AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo
1,660
Paclitaxel vs Abraxane (albumin-bound paclitaxel)
1,321
“The Molecular pathology of Breast Cancer Progression”
1,286
Recent comprehensive review on the role of ultrasound in breast cancer management
1,144
Introduction to Transdermal Drug Delivery (TDD) system and nanotechnology
1,141
Mitochondria: Origin from oxygen free environment, role in aerobic glycolysis, metabolic adaptation
1,114
Biosimilars: Intellectual Property Creation and Protection by Pioneer and by Biosimilar Manufacturers
1,040
Future of Calcitonin…?
1,034
Issues in Personalized Medicine in Cancer: Intratumor Heterogeneity andBranched Evolution Revealed by Multiregion Sequencing
947
Non-small Cell Lung Cancer drugs – where does the Future lie?
908
CD47: Target Therapy for Cancer
907
Closing the Mammography gap
890
DNA Structure and Oligonucleotides
883
Open Access Scientific Journal
855
Nitric Oxide has a ubiquitous role in the regulation of glycolysis -with a concomitant influence on mitochondrial function
851
Mitochondrial fission and fusion: potential therapeutic targets?
833
Crucial role of Nitric Oxide in Cancer
787
Biosimilars: CMC Issues and Regulatory Requirements
783
Nanotechnology: Detecting and Treating metastatic cancer in the lymph node
759
Akt inhibition for cancer treatment, where do we stand today?
749
Paradigm Shift in Human Genomics – Predictive Biomarkers and Personalized
Medicine – Part 1
747
Partnerships & Funding
739
Mitochondrial Damage and Repair under Oxidative Stress
706
Sunitinib brings Adult Acute Lymphoblastic Leukemia (ALL) to Remission – RNA Sequencing – FLT3 Receptor Blockade
695
Novel Cancer Hypothesis Suggests Antioxidants Are Harmful
689
Differentiation Therapy – Epigenetics Tackles Solid Tumors
633
Interview with the co-discoverer of the structure of DNA: Watson on The Double Helix and his changing view of Rosalind Franklin
628
Relation of Diet and Cancer
622
Big Data in Genomic Medicine
620
Immunoreactivity of Nanoparticles
609
Directions for Genomics in Personalized Medicine
587
Confined Indolamine 2, 3 dioxygenase (IDO) Controls the Hemeostasis of Immune Responses for Good and Bad
579
International Scientific Delegations
570
2013 Genomics: The Era Beyond the Sequencing of the Human Genome: Francis Collins, Craig Venter, Eric Lander, et al
536
Gamification of Genomics and Proteomics Research
531
The Development of siRNA-Based Therapies for Cancer
527
Nanotechnology Tackles Brain Cancer
524
Heroes in Medical Research: Barnett Rosenberg and the Discovery of Cisplatin
517
Ubiquitin-Proteosome pathway, Autophagy, the Mitochondrion, Proteolysis and Cell Apoptosis: Part III
517
Expanding the Genetic Alphabet and Linking the Genome to the Metabolome
516
In focus: Melanoma Genetics
510
Nanotech Therapy for Breast Cancer
509
How mobile elements in “Junk” DNA promote cancer. Part 1: Transposon-mediated tumorigenesis
500
PART 4:
Content Curations in e-Publishing
Scenario B
BioMed e-Series C: Cancer and Oncology
http://pharmaceuticalintelligence.com/biomed-e-books/series-c-e-books-on-cancer-oncology/
THREE e-Books on Cancer, Volume One, Volume Two, Volume Three
- Volume One: Cancer Biology and Genomics for Disease Diagnosis
- Volume Two: Radiation Therapy and Immunotherapy in Oncology
- Volume Three: Nanotechnology in Drug Discovery and Drug Delivery
- Volume Four: Cancer Patients’ Resources on Therapies
PART 5:
Publications on Cancer & Oncology by
LPBI’s Cancer Research Team
Scenario C
Cancer Research Team @ Leaders in Pharmaceutical Business Intelligence (LPBI) –
+10 MDs & PhDs, LPBI’s Expert, Authors, Writers
http://pharmaceuticalintelligence.com/contributors-biographies/
- Stephen J. Williams, PhD, Senior Editor
sjwilliamspa@comcast.net
Cancer Research: Curations and Reporting: Stephen J. Williams, PhD [PENDING]
- Larry H Bernstein, MD, FCAP, Chief Scientific Officer, Member of the Board, COntent COnsultant for e-Series C: Cancer & Oncology and Expert, Author, Writer on Cancer, Cell biology, Signal transduction, Biochemistry
larry.bernstein@gmail.com
Cancer Research: Curations and Reporting: Larry [PENDING]
- Tilda Barliya, PhD, Editor
tildabarliya@gmail.com
Cancer Research: Curations and Reporting: Tilda [PENDING]
- Ritu Saxena, PhD, Editor
ritu.uab@gmail.com
Cancer Research: Curations and Reporting: Ritu [PENDING]
- Dror Nir, PhD, Editor
dror.nir@radbee.com
Cancer Research: Curations and Reporting: Dror [PENDING]
- Itzhak Golan, PhD, Senior Editor Immunotherapy in Cancer
I.Golan@swansea.ac.uk
- Raphael Nir, PhD, Expert, Author, Writer on Brain Cancer
rnir@sbhsciences.com
Cancer Research: Curations and Reporting: Raphael [PENDING]
- Demet Sag, PhD, Expert, Author, Writer on Cancer Gemonics and Pharmacology
demet.sag@gmail.com
Cancer Research: Curations and Reporting: Raphael [PENDING]
- Ziv Raviv, PhD, Expert, Author, Writer on Cancer, Cell biology, Signal transduction, Biochemistry
zraviv06@gmail.com
Cancer Research: Curations and Reporting: Ziv [PENDING]
- Aviva Lev-Ari, PhD, RN, Editor-in-Chief – BioMed e-Series of e-Books
avivalev-ari@alum.berkeley.edu
Cancer Research: Curations and Reporting: Aviva Lev-Ari, PhD, RN
PART 6:
Protected: Prospective Business Partners and Valuation of Scenarios A & B & C
PART 7:
Cancer-related Pharma and Biotech Companies in Switzerland and in Germany
GERMANY
Ibt Bebig | Berlin, Germany | Cancer Treatments |
Sirtex Medical | Bonn, Germany | Cancer Treatments |
Cato Research | Cologne, Germany | Full Service Contract Research |
United Biosource (Express Scripts) | Cologne, Germany | Biopharmaceutical Consulting & Services |
IDT Biologika | Dessau-Rosslaud, Germany | Contract Research, Development & Manufacturing (Biologics, Liquid Small Molecules) |
Bayer | Leverkusen, Germany | Biotech/Pharma/Chemical Giant |
4SC | Planegg, Germany | Autoimmune & Cancer Small Molecules |
Allergopharma (Merck KgaA) | Reinbek, Germany | Specific Immunotherapy Allergy Treatment |
Biobase | Wolfenbüttel, Germany | Biological Databases |
SWITZERLAND
Genedata | Basel, Switzerland | Bioinformatics |
Carbogen Amcis | Bubendorf, Switzerland | Drug Development & Commercialization |
NovImmune | Geneva, Switzerland | Monoclonal Antibodies |
United Biosource (Express Scripts) | Geneva, Switzerland | Biopharmaceutical Consulting & Services |
Carbogen Amcis | Hunzenschwil, Switzerland | Drug Development & Commercialization |
Enzo Life Sciences | Lausen, Switzerland | Life Sciences R&D Products |
Bio-Xtal | Lutry, Switzerland | Protein Expression & Structural Biology |
Accuray | Morges, Switzerland | Directed Radiation Therapy |
Lonza | Visp, Switzerland | Small Molecules, Biologics |
PSI | Zug, Switzerland | Clinical Research Organization |
Celerion | Zurich, Switzerland | Clinical Research |
Leave a Reply